Loading…
Please wait while we prepare your analysis
| Date | Name | Title | Action | No Shares | Price Per Share |
|---|---|---|---|---|---|
Insider Transactions For REPL | |||||
| 2026-02-18 | Astley-sparke, Philip | Director | Sold | 25000 | $0.00 |
| 2025-12-19 | Xynos, Konstantinos | Chief Medical Officer | Purchased | 60000 | $0.00 |
| 2025-12-19 | Schwendenman, Andrew | Chief Accounting Officer | Purchased | 10000 | $0.00 |
| 2025-12-19 | Sarchi, Christopher | Chief Commercial Officer | Purchased | 35000 | $0.00 |
| 2025-12-19 | Hill, Emily Luisa | Chief Financial Officer | Purchased | 60000 | $0.00 |
| 2025-12-19 | Patel, Sushil | Director, Chief Executive Officer | Purchased | 200000 | $0.00 |
| 2025-12-09 | Dhingra, Kapil | Director | Sold | 3169 | $10.40 |
| 2025-12-09 | Dhingra, Kapil | Director | Purchased | 3169 | $1.75 |
| 2025-12-09 | Dhingra, Kapil | Director | Sold | 3169 | $0.00 |
| 2025-12-02 | Patel, Sushil | Director, Chief Executive Officer | Sold | 10000 | $11.13 |
| 2025-11-17 | Xynos, Konstantinos | Chief Medical Officer | Sold | 7248 | $9.10 |
| 2025-11-17 | Sarchi, Christopher | Chief Commercial Officer | Sold | 5208 | $9.10 |
| 2025-08-15 | Hill, Emily Luisa | Chief Financial Officer | Sold | 9154 | $5.37 |
| 2025-05-20 | Astley-sparke, Philip | Director | Sold | 32279 | $8.06 |
| 2025-05-20 | Schwendenman, Andrew | Chief Accounting Officer | Sold | 3287 | $8.05 |
| 2025-05-20 | Sarchi, Christopher | Chief Commercial Officer | Sold | 3749 | $8.05 |
| 2025-05-20 | Patel, Sushil | Director, Chief Executive Officer | Sold | 25105 | $8.06 |
| 2025-05-20 | Hill, Emily Luisa | Chief Financial Officer | Sold | 2535 | $8.05 |
| 2025-05-20 | Xynos, Konstantinos | Chief Medical Officer | Sold | 7952 | $8.06 |
| 2025-04-01 | Pucci, Paolo | Director | Purchased | 32000 | $0.00 |
